stockportfolio.pro
Halozyme Therapeutics, Inc. Shares Outstanding 2009–2025
Halozyme Therapeutics, Inc. (HALO) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 117.8M | -4.3% |
| FY 2024 | 123.1M | -2.9% |
| FY 2023 | 126.8M | -6.2% |
| FY 2022 | 135.2M | -1.7% |
| FY 2021 | 137.5M | +1.8% |
| FY 2020 | 135.0M | -1.2% |
| FY 2019 | 136.7M | -5.5% |
| FY 2018 | 144.7M | +1.4% |
| FY 2017 | 142.8M | +10.3% |
| FY 2016 | 129.5M | +1.1% |
| FY 2015 | 128.2M | +1.9% |
| FY 2014 | 125.7M | +9.8% |
| FY 2013 | 114.5M | +1.6% |
| FY 2012 | 112.7M | +8.4% |
| FY 2011 | 104.0M | +3.4% |
| FY 2010 | 100.6M | — |
| FY 2009 | 0.0M | — |
Source: Halozyme Therapeutics, Inc. SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Halozyme Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHalozyme Therapeutics, Inc. — frequently asked questions
What is Halozyme Therapeutics, Inc.'s shares outstanding?
Halozyme Therapeutics, Inc. (HALO) reported shares outstanding of 117.8M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Halozyme Therapeutics, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.